These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36756489)

  • 1. FACTORS CONTRIBUTING TO PULMONARY TB TREATMENT LOST TO FOLLOW-UP IN DEVELOPING COUNTRIES: AN OVERVIEW.
    Monique O; Ilse DP
    Afr J Infect Dis; 2023; 17(1):60-73. PubMed ID: 36756489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.
    Khaitan A; Rai SK; Krishnan A; Gupta SK; Kant S; Khilnani GC
    Cureus; 2022 May; 14(5):e25030. PubMed ID: 35591891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with
    Jiang Y; Chen J; Ying M; Liu L; Li M; Lu S; Li Z; Zhang P; Xie Q; Liu X; Lu H
    Front Med (Lausanne); 2023; 10():1136094. PubMed ID: 37181365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss to follow-up among patients diagnosed with spinal tuberculosis at a tertiary hospital in Western Cape Province, South Africa: A retrospective cohort study.
    Mann TN; Davis JH; Dyers R
    S Afr Med J; 2020 Mar; 110(4):284-290. PubMed ID: 32657739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review.
    Tola HH; Tol A; Shojaeizadeh D; Garmaroudi G
    Iran J Public Health; 2015 Jan; 44(1):1-11. PubMed ID: 26060770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India.
    Deshmukh RD; Dhande DJ; Sachdeva KS; Sreenivas A; Kumar AM; Satyanarayana S; Parmar M; Moonan PK; Lo TQ
    PLoS One; 2015; 10(8):e0135802. PubMed ID: 26301748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?
    Kawatsu L; Uchimura K; Ohkado A; Kato S
    PLoS One; 2018; 13(6):e0198075. PubMed ID: 29906287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors Associated with Loss to Follow-Up during Tuberculosis Treatment in the Sanatorium Hospital of Luanda, Angola.
    Vita D; Aznar ML; Martínez-Campreciós J; Kansietoko DCMS; Molina I
    Trop Med Infect Dis; 2024 Jun; 9(6):. PubMed ID: 38922043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects.
    Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN
    BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To study the impact of active case finding (ACF) among the TB patients detected in South Delhi.
    Shukla G; Sarin R; Vohra V; Khayyam KU
    Indian J Tuberc; 2021 Jan; 68(1):80-84. PubMed ID: 33641855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia.
    Kibuule D; Aiases P; Ruswa N; Rennie TW; Verbeeck RK; Godman B; Mubita M
    ERJ Open Res; 2020 Jan; 6(1):. PubMed ID: 32201689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study.
    Watumo D; Mengesha MM; Gobena T; Gebremichael MA; Jerene D
    BMC Public Health; 2022 May; 22(1):976. PubMed ID: 35568853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with non-adherence during tuberculosis treatment among patients treated with DOTS strategy in Jayapura, Papua Province, Indonesia.
    Ruru Y; Matasik M; Oktavian A; Senyorita R; Mirino Y; Tarigan LH; van der Werf MJ; Tiemersma E; Alisjahbana B
    Glob Health Action; 2018; 11(1):1510592. PubMed ID: 30394200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning algorithms using national registry data to predict loss to follow- up during tuberculosis treatment.
    Rodrigues MMS; Barreto-Duarte B; Vinhaes CL; Araújo-Pereira M; Fukutani ER; Bergamaschi KB; Kristki A; Cordeiro-Santos M; Rolla VC; Sterling TR; Queiroz ATL; Andrade BB
    Res Sq; 2023 Dec; ():. PubMed ID: 38168296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review.
    Law S; Daftary A; O'Donnell M; Padayatchi N; Calzavara L; Menzies D
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30309972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.